When considering the association between increased intracellular concentrations of uric acid and kidney damage, dotinurad specifically inhibits tubular URAT1, which may reduce levels of intracellular uric acid to a greater extent than other uricosuric drugs. The gene discussed is SLC22A12; the disease is Nephropathy.